Login
Login
Register
Complete Your Profile
Change Password
Request a Password Reset
Download Documents
Download Documents
Get Help to Participate in This Tender
Change Password
For better security, update the account password.
The ITY-RESULT _NGCONTENT-NG-C92264979="" _NGHOST-NG-C893956049="" CLASS="NG-STAR-INSERTED" BATTLEFIELD PAIN MANAGEMENT - ANALGESIC has issued a Tender notice for the procurement of a Battlefield Pain Management Analgesic in the USA. This Tender notice was published on 25 Jul 2026 and is scheduled to close on 14 Aug 2026, with an estimated Tender value of Refer Document. Interested bidders can access detailed Tender information, eligibility criteria, and complete bidding documents by referencing TOT Ref No. 145888172, while the tender notice number is HT942726RE009 and Registering on the platform.
Procurement Summary
Country: USA
Summary: Battlefield Pain Management Analgesic
Deadline: 14 Aug 2026
Posting Date: 25 Jul 2026
Other Information
Notice Type: Tender
TOT Ref.No.: 145888172
Document Ref. No.: HT942726RE009
Competition: ICB
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: Refer Document
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_detailsLogin to see details Tender Details This Request for Prototype Proposal (RPP) is being issued under the authority of prototype Other Transaction Authority (pOTA) 10 U.S.C. 4022 by the Defense Health Agency Contracting Activity (DHACA), in support of the Defense Health Agency, Portfolio Acquisition Executive Medical Products (PAE MP), Warfighter Protection and Acute Care Project Management Office (WPAC PMO) located in Frederick, Maryland, at Fort Detrick. The requirement is for Analgesic Product for Battlefield Use. Please see the attached RPP and attachments for additional information. Documents
Amendment 0001
The purpose of Amendment 0001 is to:
1. Amend the Request for Prototype Proposal (RPP) as follows:
- Extend the proposal due date from 30 July 2026 to 14 August 2026 (RPP Amendment 0001, page 1 and page 17). No additional questions/phone calls regarding the RPP will be accepted.
- Update the word “drug” to “product” to align with the language (RPP Amendment 0001, page 2, section 1.1, third paragraph)
- Clarify language regarding the Spend Plan (RPP Amendment 0001, page 13, section 3.5 Volume III: Administrative and Cost Volume, Attachment E - Cost Sheet Template with priced milestones, first paragraph).
- Add additional Vendor requirements (RPP Amendment 0001, page 15, section 3.5 Volume III: Administrative and Cost Volume, Other Administrative Requirements).
2. Amend the RPP, Attachment A - Statement of Objectives (SOO) as follows:
- Update the Revised Date (page 1).
- Update language throughout to clarify the Government-s intent regarding drug versus product.
- page 1, section 1. Purpose/Objective, second and third paragraphs
- page 2, section 4 Objectives, second, third and fifth paragraphs
- page 3, section 4 Objectives, first paragraph
- page 5, Desirable prototype characteristics and performance, first paragraph
- Revise the following Desirable prototype characteristics and performance: (2), (6), (9), and (13) (page 5 and page 6).
- Revise ...
Notice ID: ht942726re009
Department/Ind. Agency: dept of defense
Sub-tier: defense health agency (dha)
Office: defense health agency
Product Service Code: an13 - health r&d services; health care services; experimental development
NAICS Code: 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Inactive Dates: dec 31, 2026
Inactive Policy: manual
Procurement Documents for USA
Access a comprehensive library of standard procurement documents specific to USA. Here, you'll find all the essential forms, guidelines, and templates required for tender applications and submissions in USA
Want To Bid in This Tender?
Get Local Agent Support in USA and 60 More Countries.
View Tenders By
Sign in with Google